Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 3 Hydroxybutyric Acid Ethyl Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101392225A reveals a recombinant yeast route for high-purity (S)-CHBE, offering significant cost reduction in API manufacturing and robust supply chain scalability.
Patent CN112680425B reveals a novel alcohol dehydrogenase mutant for producing high-purity (S)-CHBE. This biocatalytic route offers significant cost reduction and supply chain reliability for statin manufacturing.
Patent CN104651292A reveals high-purity S-CHBE synthesis via recombinant E. coli. Achieves 100% conversion and 99.4% ee for scalable pharmaceutical intermediates.
Patent CN101824438B details microbial synthesis of high-purity (S)-EHB using yeast. Offers cost-effective, scalable pharmaceutical intermediate solutions.
Patent CN101824438A reveals microbial conversion for high-purity chiral intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing partners globally.